// App-Quantinova.ai

: Acute and late toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated pelvic radiotherapy.

Researchers

Presenter

  • Sergio Faria

Principal Investigators

  • Russel RUO

  • Fabio Cury

  • Marie Duclos

  • Luis Souhami

Medical Centers

  • Montreal University, Montreal, QC, Canada

  • Centre Universitaire de Sante McGill, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02107287

Sponsors

  • N/A

Result

  • N/A